It has been suggested that modifications in the tumor microenvironment, such as increased levels of TNF-α, interferon-gamma, T cell infiltration, and reduced levels of interleukin-6 and interleukin-8, could be associated with irAEs and treatment outcomes. The gene discussed is TNF; the disease is neoplasm.